Citation Impact

Citing Papers

Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme
2008
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
TREM2 in Neurodegenerative Diseases
2017
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”
2006
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
2007
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
The spectrum of neuromyelitis optica
2007 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
The future of high-grade glioma: Where we are and where are we going
2015
Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature
2000
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis
2015
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Medical management of brain tumors and the sequelae of treatment
2014
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
Autonomic asymmetry in migraine: augmented parasympathetic activation in left unilateral migraineurs
2004
CR3 (CD11b/CD18) and CR4 (CD11c/CD18) Are Involved in Complement-Independent Antibody-Mediated Phagocytosis of Cryptococcus neoformans
2002
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
2013
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
2010
Do carer’s levels of unmet needs change over time when caring for patients diagnosed with high-grade glioma and how are these needs correlated with distress?
2017
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Headache related to brain tumors
2006
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study
2008
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
Hypothalamic activation in cluster headache attacks
1998 Standout
Alterations in the brain GABAA/benzodiazepine receptor-chloride ionophore complex in a genetic model of paroxysmal dystonia: A quantitative autoradiographic analysis
1995
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
2019
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
1997 Standout
Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition
2010
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
A comprehensive outlook on intracerebral therapy of malignant gliomas
2010
Malignant Gliomas in Adults
2008 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
2002
Spleen deposition ofCryptococcus neoformanscapsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1
2008 StandoutNobel
Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?
1996
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Systemic Autoimmune Features and Multiple Sclerosis
1998
Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism
2015
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Primary brain tumours in adults
2012 Standout
Human brucellosis
2007 Standout
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study
2008
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Pathophysiology of cluster headache: a trigeminal autonomic cephalgia
2002
The effectiveness of e-Health interventions on caregiver burden, depression, and quality of life in informal caregivers of patients with cancer: A systematic review and meta-analysis of randomized controlled trials
2022 Standout
Immunity to fungal infections
2011 Standout
Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances
2006
Photoplethysmography and its application in clinical physiological measurement
2007 Standout
Passive Immunotherapeutic Strategies for the Treatment of Malignant Gliomas
2012
Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
2010
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Serum Cholesterol Levels and the Risk of Parkinson's Disease
2006
Neuroendocrine Dysfunction in Cluster Headache
1990
Animal Models of Parkinsonism Using Selective Neurotoxins: Clinical and Basic Implications
1989
Management of glioblastoma: State of the art and future directions
2020 Standout
Assessing mitochondrial dysfunction in cells
2011 Standout
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice
1994
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Migraine: A Chronic Sympathetic Nervous System Disorder
2004
Neue Ziele für die Photopharmakologie
2016 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Sodium Valproate in The Prophylactic Treatment of Migraine: A Double-Blind Study Versus Placebo
1992
Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study
2009
Aspergillus fumigatusand Aspergillosis
1999 Standout
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
1993
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Neurobrucellosis: clinical and neuroimaging correlation.
2004
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Antibody immunity and invasive fungal infections
1995
Spinal cord abnormalities in recently diagnosed MS patients
2004
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society.
1997 Standout

Works of E. Lamperti being referenced

Transient Paroxysmal Dystonia in Infancy
1988
Infections in neuro-oncology
2011
Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL): A new report of an Italian woman and review of the literature
2013
Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience
2006
Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience
2013
Phase II Trial of Cisplatin Plus Temozolomide, in Recurrent and Progressive Malignant Glioma Patients
2004
Headache in brain tumours: a symptom to reappraise critically
2004
Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas
2009
Decreased Cholesterol Biosynthesis in Fibroblasts from Patients with Parkinson Disease
1993
Living with a brain tumor
2012
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma
2005
Bevacizumab at recurrence in high-grade glioma
2011
Neurobrucellosis Mimicking Multiple Sclerosis: A Case Report
1989
Treatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?
2008
Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48
2014
Piribedil Test in Migraine: Neruoendocrinological Aspects
1986
Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients.
1994
Cryptococcal meningoencephalitis: intrathecal immunological response
1986
Trh-Test In Cluster Headache
1987
Impaired Cardiovascular Reflexes in Cluster Headache and Migraine Patients: Evidence for an Autonomic Dysfunction
1988
Cluster Headache Patients' Responses to Dexamethasone Suppression Test
1988
Possible involvement of attention processes in Parkinson's disease.
1987
New approach in delivering chemotherapy: locoregional treatment for recurrent glioblastoma (rGBM).
2003
TRH test in cluster headache.
1988
Rankless by CCL
2026